Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Eitan P. Amir
Based on 65 articles published since 2009
(Why 65 articles?)
||||
Expertise Level
The expertise of Eitan P. Amir ranks in the
  • Top 0.049%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 65 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Amir, Eitan   ·   Amir, Eitan P   ·   Amir, E
Work Locations
Details
Most likely:    University Health Network of Toronto      
2019
  • Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 30929116
  • Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Cancerología (INCan), Unidad de Cardio-Oncología, Mexico City, Mexico. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 30760421
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya, 02006 Albacete, Spain. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 30366201
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; King Fahad Medical City, Riyadh, Saudi Arabia. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; Davidoff Cancer Centre, Beilinson Hospital and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30176513
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, 1000, Ljubljana, Slovenia. · Translational Research Unit, Albacete University Hospital and CIBERONC, calle Francisco Javier de Moya, 02006, Albacete, Spain. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 29423899
  • Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Medical Oncology, St Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: · Pubmed 29126017
  • Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Suite 130, Toronto, ON, M5T1P8, Canada. · Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Suite 130, Toronto, ON, M5T1P8, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. · Department of Oncology, Kinghorn Cancer Centre and the Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia. · Division of Geriatric Medicine, McGill University, Montreal, QC, Canada. · Department of Medicine and Institute of Health Policy, Management, and Evaluation, University Health Network and University of Toronto, Toronto, ON, Canada. · Pubmed 28741175
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Toronto General Hospital, University Health Network · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ying Liu, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29791284
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
  • Department of Medical Oncology, Kingston Health Sciences Centre, Queen's University, Kingston, Ontario, Canada. · Complejo Hospitalario de Albacete, Albacete, Spain; GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Instituto Valenciano de Oncología, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Virgen de La Victoria, Málaga, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Univ. Virgen Del Rocío, Sevilla, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario La Fe, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Ramón y Cajal, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro Oncológico de Galicia, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Cabueñes, Gijón, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Donostia, San Sebastián, Spain. · GEICAM (Spanish Breast Cancer Group), Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Electronic address: · Pubmed 29573665
  • Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29351960
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Division of Medical Oncology, University of Toronto and Princess Margaret Hospital, Toronto, Canada. · Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 28453506
  • Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Pubmed 28355581
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Pubmed 28251493
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, Switzerland. · Institute of Health Policy and Management Evaluation, University of Toronto, Toronto, Canada. · Department of Paediatrics, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Pubmed 28057046
  • Paaladinesh Thavendiranathan, Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28029315
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC, Salamanca, Spain. · Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Pubmed 29235520
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain. · Yale Cancer Center, Yale University, New Haven, USA. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 28423514
  • Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada. · Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Cancer Clinical Research Unit, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada2Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada4Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada5Dalla Lana School of Public Health, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28278319
  • Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street suite 130, Toronto, ON, M5T1P8, Canada. · Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street suite 130, Toronto, ON, M5T1P8, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. · Kinghorn Cancer Centre and the Garvan Institute of Medical Research, University of Newsouth Wales, Sydney, Australia. · Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. · Department of Medicine and Institute of Health Policy, Management, and Evaluation, University Health Network and University of Toronto, Toronto, ON, Canada. · Pubmed 27830393
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada4Division of Cardiology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada6Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada7Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada8Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Pubmed 27732702
2016
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 27235162
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
  • University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. · University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. Electronic address: · Pubmed 26922660
  • Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, 610 University Ave, M5G 2M9, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. Electronic address: · Pubmed 27693889
  • Division of Medical Oncology, BC Cancer Agency, Vancouver Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Electronic address: · Pubmed 27212696
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Pubmed 27197164
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Peter Munk Cardiac Centre and the Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto General Hospital, University of Toronto · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 27091709
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Cancer Research Center (CIC-IBMCC), CSIC-University of Salamanca, Salamanca, Spain. · IBSAL, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Pubmed 27074567
  • Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · IBMCC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 26897635
2015
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Pubmed 25857548
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Escuela de Enfermeria, Universidad de Salamanca, Salamanca, Spain. · Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Cardiología, Complejo Hospitalario de Salamanca, Salamanca, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Pubmed 26161666
  • Department of Medical Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, MB, R3E 0V9, Canada. Electronic address: · Medical Oncology Department, Albacete University Hospital and AECC Unit, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University of Toronto, Toronto, Canada. · Pubmed 26112664
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • The Ottawa Hospital Cancer Center and University of Ottawa, Ottawa, ON, Canada. · Division of Medical Oncology, The Ottawa Hospital Cancer Centre, 501 Smyth Road, Box 900, Ottawa, ON, K1H 8L6, Canada. · University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada. · The Ottawa Hospital Cancer Center and University of Ottawa, Ottawa, ON, Canada. · Department of Oncology, Division of Medical Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada. · Division of Medical Oncology, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Pubmed 25933700
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology, University Hospital, Albacete, Spain. · Department of Oncology, McMaster University, Hamilton, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 25728257
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
  • Albacete University Hospital, Albacete, Spain · Albacete University Hospital, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cancer-Centro Superior de Investigaciones Científicas, Universidad de Salamanca, Salamanca, Spain. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · Pubmed 25753437
  • Translational Oncology Research Unit, Albacete University Hospital, Albacete 02006, Spain. Electronic address: · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 25706463
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. · Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia. · IBMCC-CSIC, Universidad de Salamanca, Spain. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 25217796
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada ; Ministry of Higher Education, Riyadh, Saudi Arabia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 24586311
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Ave 5-124, Toronto, ON M5G 2M9, Canada. · Pubmed 22988040
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Research Unit, Albacete University Hospital, Albacete, Spain; Translational Oncology Laboratory, Regional Center for Biomedical Research, Castilla La Mancha University, Albacete, Spain. · Pubmed 28922781
  • Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29151109
2014
  • Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada, · Pubmed 24928527
2013
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada. · Pubmed 23764179
  • *Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Hospital ‡Ambulatory Care, Princess Margaret Hospital §Toronto General Research Institute, University of Toronto and University Health Network ∥Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto †Department of Medical Oncology, R.S. McLaughlin Durham Regional Cancer Centre, Oshawa ¶Division of Medical Oncology, University of Ottawa and The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada. · Pubmed 22781385
  • Division of Medical Oncology & Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Pubmed 23303339
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
Probable:    University of Toronto   Contact    
2019
  • Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 30929116
  • Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Cancerología (INCan), Unidad de Cardio-Oncología, Mexico City, Mexico. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 30760421
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya, 02006 Albacete, Spain. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 30366201
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; King Fahad Medical City, Riyadh, Saudi Arabia. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; Davidoff Cancer Centre, Beilinson Hospital and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30176513
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, 1000, Ljubljana, Slovenia. · Translational Research Unit, Albacete University Hospital and CIBERONC, calle Francisco Javier de Moya, 02006, Albacete, Spain. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 29423899
  • Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Medical Oncology, St Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: · Pubmed 29126017
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Toronto General Hospital, University Health Network · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ying Liu, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29791284
  • Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29351960
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Division of Medical Oncology, University of Toronto and Princess Margaret Hospital, Toronto, Canada. · Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 28453506
  • Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Pubmed 28355581
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Pubmed 28251493
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, Switzerland. · Institute of Health Policy and Management Evaluation, University of Toronto, Toronto, Canada. · Department of Paediatrics, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Pubmed 28057046
  • Paaladinesh Thavendiranathan, Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28029315
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC, Salamanca, Spain. · Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Pubmed 29235520
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain. · Yale Cancer Center, Yale University, New Haven, USA. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 28423514
  • Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada. · Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Cancer Clinical Research Unit, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada2Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada4Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada5Dalla Lana School of Public Health, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28278319
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada4Division of Cardiology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada6Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada7Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada8Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Pubmed 27732702
2016
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 27235162
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
  • University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. · University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. Electronic address: · Pubmed 26922660
  • Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, 610 University Ave, M5G 2M9, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. Electronic address: · Pubmed 27693889
  • Division of Medical Oncology, BC Cancer Agency, Vancouver Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Electronic address: · Pubmed 27212696
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Pubmed 27197164
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Peter Munk Cardiac Centre and the Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto General Hospital, University of Toronto · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 27091709
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Cancer Research Center (CIC-IBMCC), CSIC-University of Salamanca, Salamanca, Spain. · IBSAL, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Pubmed 27074567
  • Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · IBMCC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 26897635
2015
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Pubmed 25857548
  • Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada. · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H3A 1A3, Canada. · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montréal, QC H3A 1A3, Canada. · Department of Pathology, McGill University Health Center, Montréal, QC H4A 3J1, Canada. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada. · Department of Medicine, University of Toronto, Toronto, ON M5G 2M9, Canada. · Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada. · Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montréal, QC H3T 1E2, Canada. · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montréal, QC H3A 1A3, Canada. Electronic address: · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H3A 1A3, Canada. Electronic address: · Pubmed 26365179
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Escuela de Enfermeria, Universidad de Salamanca, Salamanca, Spain. · Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Cardiología, Complejo Hospitalario de Salamanca, Salamanca, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Pubmed 26161666
  • Department of Medical Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, MB, R3E 0V9, Canada. Electronic address: · Medical Oncology Department, Albacete University Hospital and AECC Unit, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University of Toronto, Toronto, Canada. · Pubmed 26112664
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology, University Hospital, Albacete, Spain. · Department of Oncology, McMaster University, Hamilton, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 25728257
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
  • Albacete University Hospital, Albacete, Spain · Albacete University Hospital, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cancer-Centro Superior de Investigaciones Científicas, Universidad de Salamanca, Salamanca, Spain. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · Pubmed 25753437
  • Translational Oncology Research Unit, Albacete University Hospital, Albacete 02006, Spain. Electronic address: · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 25706463
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. · Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia. · IBMCC-CSIC, Universidad de Salamanca, Spain. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 25217796
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada ; Ministry of Higher Education, Riyadh, Saudi Arabia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 24586311
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Research Unit, Albacete University Hospital, Albacete, Spain; Translational Oncology Laboratory, Regional Center for Biomedical Research, Castilla La Mancha University, Albacete, Spain. · Pubmed 28922781
  • Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29151109
2015
  • From the 1Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada; 2Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; and 3Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 25692874
2014
  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada. · Pubmed 24771048
2013
  • *Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Hospital ‡Ambulatory Care, Princess Margaret Hospital §Toronto General Research Institute, University of Toronto and University Health Network ∥Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto †Department of Medical Oncology, R.S. McLaughlin Durham Regional Cancer Centre, Oshawa ¶Division of Medical Oncology, University of Ottawa and The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada. · Pubmed 22781385
  • Division of Medical Oncology & Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Pubmed 23303339
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
Probable:    University of Illinois Chicago   Contact    
2015
  • University of Maryland Medical Center, Baltimore, MD 21201, United States. · Department of Plastic and Reconstructive Surgery, PLA General Hospital, Beijing, 100853, China. · Brown University, Providence, RI 02912, United States. · University of Wisconsin, Madison, WI 53706, United States. · University of Illinois, Chicago, IL 60607, United States. · University of Texas, Austin, TX 78712, United States. · University of Texas, Austin, TX 78712, United States. Electronic address: · University of Texas, Austin, TX 78712, United States. Electronic address: · Ohio State University, Columbus, OH 43210, United States. · University of Illinois, Chicago, IL 60607, United States. Electronic address: · University of Illinois, Chicago, IL 60607, United States. Electronic address: · University of Illinois, Chicago, IL 60607, United States. Electronic address: · Pubmed 26141233
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 65 total) written by Eitan P. Amir about Breast Neoplasms:

  • Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis. 2019
  • Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy. 2019
  • Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis. 2018
  • Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy. 2018
  • Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis. 2018
  • Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis. 2018
  • Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis. 2018
  • A randomized phase II trial of geriatric assessment and management for older cancer patients. 2018
  • Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer. 2018
  • Risk-Imaging Mismatch in Cardiac Imaging Practices for Women Receiving Systemic Therapy for Early-Stage Breast Cancer: A Population-Based Cohort Study. 2018
Show List of Full Article Records
Google Searches

Learn more about Eitan P. Amir using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University Health Network of Toronto
University of Toronto
University of Illinois Chicago
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University Health Network of Toronto
2019
  • Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 30929116
  • Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Cancerología (INCan), Unidad de Cardio-Oncología, Mexico City, Mexico. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 30760421
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya, 02006 Albacete, Spain. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 30366201
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; King Fahad Medical City, Riyadh, Saudi Arabia. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; Davidoff Cancer Centre, Beilinson Hospital and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30176513
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, 1000, Ljubljana, Slovenia. · Translational Research Unit, Albacete University Hospital and CIBERONC, calle Francisco Javier de Moya, 02006, Albacete, Spain. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 29423899
  • Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Medical Oncology, St Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: · Pubmed 29126017
  • Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Suite 130, Toronto, ON, M5T1P8, Canada. · Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Suite 130, Toronto, ON, M5T1P8, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. · Department of Oncology, Kinghorn Cancer Centre and the Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia. · Division of Geriatric Medicine, McGill University, Montreal, QC, Canada. · Department of Medicine and Institute of Health Policy, Management, and Evaluation, University Health Network and University of Toronto, Toronto, ON, Canada. · Pubmed 28741175
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Toronto General Hospital, University Health Network · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ying Liu, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29791284
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
  • Department of Medical Oncology, Kingston Health Sciences Centre, Queen's University, Kingston, Ontario, Canada. · Complejo Hospitalario de Albacete, Albacete, Spain; GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Instituto Valenciano de Oncología, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Virgen de La Victoria, Málaga, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Univ. Virgen Del Rocío, Sevilla, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario La Fe, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Ramón y Cajal, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro Oncológico de Galicia, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Cabueñes, Gijón, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Donostia, San Sebastián, Spain. · GEICAM (Spanish Breast Cancer Group), Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Electronic address: · Pubmed 29573665
  • Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29351960
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Division of Medical Oncology, University of Toronto and Princess Margaret Hospital, Toronto, Canada. · Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 28453506
  • Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Pubmed 28355581
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Pubmed 28251493
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, Switzerland. · Institute of Health Policy and Management Evaluation, University of Toronto, Toronto, Canada. · Department of Paediatrics, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Pubmed 28057046
  • Paaladinesh Thavendiranathan, Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28029315
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC, Salamanca, Spain. · Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Pubmed 29235520
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain. · Yale Cancer Center, Yale University, New Haven, USA. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 28423514
  • Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada. · Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Cancer Clinical Research Unit, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada2Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada4Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada5Dalla Lana School of Public Health, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28278319
  • Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street suite 130, Toronto, ON, M5T1P8, Canada. · Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street suite 130, Toronto, ON, M5T1P8, Canada. · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. · Kinghorn Cancer Centre and the Garvan Institute of Medical Research, University of Newsouth Wales, Sydney, Australia. · Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. · Department of Medicine and Institute of Health Policy, Management, and Evaluation, University Health Network and University of Toronto, Toronto, ON, Canada. · Pubmed 27830393
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada4Division of Cardiology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada6Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada7Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada8Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Pubmed 27732702
2016
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 27235162
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
  • University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. · University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. Electronic address: · Pubmed 26922660
  • Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, 610 University Ave, M5G 2M9, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. Electronic address: · Pubmed 27693889
  • Division of Medical Oncology, BC Cancer Agency, Vancouver Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Electronic address: · Pubmed 27212696
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Pubmed 27197164
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Peter Munk Cardiac Centre and the Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto General Hospital, University of Toronto · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 27091709
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Cancer Research Center (CIC-IBMCC), CSIC-University of Salamanca, Salamanca, Spain. · IBSAL, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Pubmed 27074567
  • Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · IBMCC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 26897635
2015
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Pubmed 25857548
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Escuela de Enfermeria, Universidad de Salamanca, Salamanca, Spain. · Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Cardiología, Complejo Hospitalario de Salamanca, Salamanca, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Pubmed 26161666
  • Department of Medical Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, MB, R3E 0V9, Canada. Electronic address: · Medical Oncology Department, Albacete University Hospital and AECC Unit, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University of Toronto, Toronto, Canada. · Pubmed 26112664
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • The Ottawa Hospital Cancer Center and University of Ottawa, Ottawa, ON, Canada. · Division of Medical Oncology, The Ottawa Hospital Cancer Centre, 501 Smyth Road, Box 900, Ottawa, ON, K1H 8L6, Canada. · University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada. · The Ottawa Hospital Cancer Center and University of Ottawa, Ottawa, ON, Canada. · Department of Oncology, Division of Medical Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada. · Division of Medical Oncology, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Pubmed 25933700
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology, University Hospital, Albacete, Spain. · Department of Oncology, McMaster University, Hamilton, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 25728257
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
  • Albacete University Hospital, Albacete, Spain · Albacete University Hospital, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cancer-Centro Superior de Investigaciones Científicas, Universidad de Salamanca, Salamanca, Spain. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · Pubmed 25753437
  • Translational Oncology Research Unit, Albacete University Hospital, Albacete 02006, Spain. Electronic address: · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 25706463
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. · Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia. · IBMCC-CSIC, Universidad de Salamanca, Spain. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 25217796
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada ; Ministry of Higher Education, Riyadh, Saudi Arabia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 24586311
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Ave 5-124, Toronto, ON M5G 2M9, Canada. · Pubmed 22988040
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Research Unit, Albacete University Hospital, Albacete, Spain; Translational Oncology Laboratory, Regional Center for Biomedical Research, Castilla La Mancha University, Albacete, Spain. · Pubmed 28922781
  • Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29151109
2014
  • Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada, · Pubmed 24928527
2013
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada. · Pubmed 23764179
  • *Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Hospital ‡Ambulatory Care, Princess Margaret Hospital §Toronto General Research Institute, University of Toronto and University Health Network ∥Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto †Department of Medical Oncology, R.S. McLaughlin Durham Regional Cancer Centre, Oshawa ¶Division of Medical Oncology, University of Ottawa and The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada. · Pubmed 22781385
  • Division of Medical Oncology & Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Pubmed 23303339
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
University of Toronto
2019
  • Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski St, Petach Tikva, Israel. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 30929116
  • Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Cancerología (INCan), Unidad de Cardio-Oncología, Mexico City, Mexico. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 30760421
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya, 02006 Albacete, Spain. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 30366201
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; King Fahad Medical City, Riyadh, Saudi Arabia. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada; Davidoff Cancer Centre, Beilinson Hospital and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30176513
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, 1000, Ljubljana, Slovenia. · Translational Research Unit, Albacete University Hospital and CIBERONC, calle Francisco Javier de Moya, 02006, Albacete, Spain. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 29423899
  • Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Medical Oncology, St Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: · Pubmed 29126017
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Toronto General Hospital, University Health Network · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ying Liu, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29791284
  • Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · University Health Network-Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29351960
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Division of Medical Oncology, University of Toronto and Princess Margaret Hospital, Toronto, Canada. · Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 28453506
  • Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, 200 Elizabeth Street, Suite RFE3-805, Toronto, Ontario, M5G 2C4, Canada. Electronic address: · Pubmed 28355581
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Ave 5-124, Toronto, ON, M5G 2M9, Canada. · Pubmed 28251493
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, Switzerland. · Institute of Health Policy and Management Evaluation, University of Toronto, Toronto, Canada. · Department of Paediatrics, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Pubmed 28057046
  • Paaladinesh Thavendiranathan, Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28029315
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC, Salamanca, Spain. · Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB) and CIBERONC, Castilla La Mancha University, Albacete, Spain. · Pubmed 29235520
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain. · Yale Cancer Center, Yale University, New Haven, USA. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 28423514
  • Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada. · Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Cancer Clinical Research Unit, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada2Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada4Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. · Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada5Dalla Lana School of Public Health, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 28278319
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada4Division of Cardiology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada6Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada7Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Toronto, Ontario, Canada5Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada8Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada9Women's College Research Institute, Toronto, Ontario, Canada. · Pubmed 27732702
2016
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 27235162
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
  • University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. · University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. Electronic address: · Pubmed 26922660
  • Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, 610 University Ave, M5G 2M9, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Hospital, 76 Grenville Street, M5S1B2, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. · Department of Medicine, University of Toronto, Suite RFE 3-805, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Peter Munk Cardiac Centre and Joint Department of Medical Imaging, University Health Network, 585 University Ave, M5G 2N2, Toronto, Ontario, Canada. · Institute for Clinical Evaluative Sciences, G1 06, 2075 Bayview Ave, M4N 3M5, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, M5T 3M6, Toronto, Ontario, Canada; Women's College Research Institute, 7th Floor, 790 Bay Street, M5G 1N8, Toronto, Ontario, Canada. Electronic address: · Pubmed 27693889
  • Division of Medical Oncology, BC Cancer Agency, Vancouver Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Electronic address: · Pubmed 27212696
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Pubmed 27197164
  • Paaladinesh Thavendiranathan and Douglas S. Lee, Peter Munk Cardiac Centre and the Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto General Hospital, University of Toronto · Husam Abdel-Qadir, Women's College Hospital · Hadas D. Fischer, Ximena Camacho, Peter C. Austin, and Douglas S. Lee, Institute for Clinical Evaluative Sciences · and Eitan Amir, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 27091709
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Cancer Research Center (CIC-IBMCC), CSIC-University of Salamanca, Salamanca, Spain. · IBSAL, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Pubmed 27074567
  • Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · IBMCC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 26897635
2015
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M6, Canada. · Pubmed 25857548
  • Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada. · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H3A 1A3, Canada. · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montréal, QC H3A 1A3, Canada. · Department of Pathology, McGill University Health Center, Montréal, QC H4A 3J1, Canada. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada. · Department of Medicine, University of Toronto, Toronto, ON M5G 2M9, Canada. · Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada. · Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montréal, QC H3T 1E2, Canada. · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montréal, QC H3A 1A3, Canada. Electronic address: · Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H3A 1A3, Canada. Electronic address: · Pubmed 26365179
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Escuela de Enfermeria, Universidad de Salamanca, Salamanca, Spain. · Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Cardiología, Complejo Hospitalario de Salamanca, Salamanca, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Pubmed 26161666
  • Department of Medical Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, MB, R3E 0V9, Canada. Electronic address: · Medical Oncology Department, Albacete University Hospital and AECC Unit, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University of Toronto, Toronto, Canada. · Pubmed 26112664
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology, University Hospital, Albacete, Spain. · Department of Oncology, McMaster University, Hamilton, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 25728257
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
  • Albacete University Hospital, Albacete, Spain · Albacete University Hospital, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cancer-Centro Superior de Investigaciones Científicas, Universidad de Salamanca, Salamanca, Spain. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · Pubmed 25753437
  • Translational Oncology Research Unit, Albacete University Hospital, Albacete 02006, Spain. Electronic address: · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 25706463
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. · Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia. · IBMCC-CSIC, Universidad de Salamanca, Spain. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 25217796
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada ; Ministry of Higher Education, Riyadh, Saudi Arabia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 24586311
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Research Unit, Albacete University Hospital, Albacete, Spain; Translational Oncology Laboratory, Regional Center for Biomedical Research, Castilla La Mancha University, Albacete, Spain. · Pubmed 28922781
  • Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29151109
2015
  • From the 1Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada; 2Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; and 3Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 25692874
2014
  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada. · Pubmed 24771048
2013
  • *Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Hospital ‡Ambulatory Care, Princess Margaret Hospital §Toronto General Research Institute, University of Toronto and University Health Network ∥Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto †Department of Medical Oncology, R.S. McLaughlin Durham Regional Cancer Centre, Oshawa ¶Division of Medical Oncology, University of Ottawa and The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada. · Pubmed 22781385
  • Division of Medical Oncology & Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Pubmed 23303339
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
University of Illinois Chicago
2015
  • University of Maryland Medical Center, Baltimore, MD 21201, United States. · Department of Plastic and Reconstructive Surgery, PLA General Hospital, Beijing, 100853, China. · Brown University, Providence, RI 02912, United States. · University of Wisconsin, Madison, WI 53706, United States. · University of Illinois, Chicago, IL 60607, United States. · University of Texas, Austin, TX 78712, United States. · University of Texas, Austin, TX 78712, United States. Electronic address: · University of Texas, Austin, TX 78712, United States. Electronic address: · Ohio State University, Columbus, OH 43210, United States. · University of Illinois, Chicago, IL 60607, United States. Electronic address: · University of Illinois, Chicago, IL 60607, United States. Electronic address: · University of Illinois, Chicago, IL 60607, United States. Electronic address: · Pubmed 26141233
8 Other Locations Show
Yearly article counts 21313912763000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.